Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2023 12.35%
June 30, 2023 -74.59%
March 31, 2023 -37.81%
December 31, 2022 -76.44%
September 30, 2022 -45.56%
June 30, 2022 -47.43%
March 31, 2022 -50.19%
December 31, 2021 -156.8%
September 30, 2021 -93.51%
June 30, 2021 -53.15%
March 31, 2021 -27.57%
December 31, 2020 -57.04%
September 30, 2020 -59.90%
June 30, 2020
March 31, 2020 46.74%
December 31, 2019 -118.3%
September 30, 2019 -507.0%
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018 -93.23%
June 30, 2018 -15.89%
March 31, 2018 -234.1%
December 31, 2017 -190.5%
September 30, 2017 -573.1%
Date Value
June 30, 2017 -9.51K%
March 31, 2017 -86.10K%
December 31, 2016 -7.10K%
September 30, 2016 -4.27K%
June 30, 2016 -8.73K%
March 31, 2016 -870.8%
December 31, 2015 -2.74K%
September 30, 2015 -772.5%
June 30, 2015 -870.4%
March 31, 2015 -1.27K%
December 31, 2014 -443.9%
September 30, 2014 -353.5%
June 30, 2014 -369.3%
March 31, 2014 -79.95%
December 31, 2013 -214.0%
September 30, 2013 -104.6%
June 30, 2013 -34.77%
March 31, 2013 40.72%
December 31, 2012 15.36%
September 30, 2012 21.94%
June 30, 2012 -88.09%
March 31, 2012 -124.6%
December 31, 2011 -365.1%
September 30, 2011 -130.1%
June 30, 2011 -14.70%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
The Cigna Group 0.00%
Centene Corp. 0.00%
CorVel Corp. 22.71%
CVS Health Corp. 14.85%
Humana, Inc. 0.00%